Neurological diseases such as Alzheimer's disease, Parkinson's disease, and stroke pose significant global health and economic challenges, affecting millions of individuals worldwide. These conditions are characterized by progressive cognitive and motor decline, severely impacting patients' quality of life. Despite advances in symptomatic treatments, current therapeutic approaches remain largely inadequate in addressing the root causes of these diseases, as they only provide temporary relief rather than halting or reversing the neurodegenerative processes. The mitochondrial dysfunction and subsequent neuronal death at the core of these conditions remain poorly targeted by existing treatments, highlighting the urgent need for novel therapeutic strategies capable of both mitigating symptoms and promoting regeneration of neural tissues.